Form 8-K - Current report:
SEC Accession No. 0001410939-22-000080
Filing Date
2022-07-05
Accepted
2022-07-05 07:36:18
Documents
14
Period of Report
2022-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20220630.htm   iXBRL 8-K 42481
2 EX-99.1 iseedelsitechagreementfina.htm EX-99.1 19619
6 image_0a.jpg GRAPHIC 12779
  Complete submission text file 0001410939-22-000080.txt   223369

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20220630.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20220630_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20220630_pre.xml EX-101.PRE 12525
8 EXTRACTED XBRL INSTANCE DOCUMENT isee-20220630_htm.xml XML 10555
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 221063203
SIC: 2834 Pharmaceutical Preparations